The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.
Fergus Manford
Advertisement
Fergus Manford is patent attorney, intellectual property, Vectura.
Articles by Fergus Manford
Advertisement
Latest Updated Articles
Integrated Approach Facilitates Inhalation Drug DevelopmentPublished: August 1st 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
3
Standardizing Operations to Meet Global Sustainability and Resilience Goals
4
The Bio/pharma Industry Navigates AI’s Impact on Workforce and Hiring
5
